{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:11:39Z","timestamp":1792141899507,"version":"4.4.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:sec id=\"ab-noi250029-4\"><jats:title>Importance<\/jats:title><jats:p>Understanding the risk factors for symptom development will allow clinicians to stratify people with radiologically isolated syndrome (pwRIS) more effectively and tailor their management strategies accordingly.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-5\"><jats:title>Objective<\/jats:title><jats:p>To identify prognostic factors at radiologically isolated syndrome (RIS) diagnosis associated with the development of multiple sclerosis (MS) symptoms.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study was performed in samples collected between July 2004 and September 2022 and included 33 MS centers. All pwRIS who meet the 2017 McDonald criteria for dissemination in space with a sample collected near the diagnostic magnetic resonance imaging were included. No patients who met eligibility criteria were excluded. The data were analyzed from July 2024 to November 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-7\"><jats:title>Exposure<\/jats:title><jats:p>Body fluid biomarkers and environmental factors in pwRIS.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-8\"><jats:title>Main outcomes and measures<\/jats:title><jats:p>The main outcome was the development of MS symptoms. Analyses involved univariable and multivariable Cox proportional hazards models, including age, sex, and treatment following RIS diagnosis, as additional independent variables.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-9\"><jats:title>Results<\/jats:title><jats:p>The study included 273 pwRIS (mean age, 38.6 [SD 11.6] years; 207 women [75.8%] and 66 men [24.2%]) with a median follow-up of 5.0 [IQR, 2.5-7.7] years. A total of 101 pwRIS developed MS symptoms (37.0%). The presence of immunoglobulin G oligoclonal bands (OBs) (hazard ratio [HR], 5.09; 95% CI, 2.36-10.97; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), immunoglobulin M OBs (HR, 2.58; 95% CI, 1.61-4.14; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), and a \u03ba free light chain index of 6.1 or more (HR, 2.79; 95% CI, 1.37-5.67; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u2009.005) were associated with MS symptoms. High cerebrospinal fluid neurofilament light chain (NfL) levels (HR, 1.31; 95% CI, 1.18-1.45; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and high serum NfL <jats:italic toggle=\"yes\">z<\/jats:italic> scores (HR, 1.42; 95% CI, 1.16-1.72; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u2009.005) were also associated with an increased risk of MS symptoms. In contrast, high anti-cytomegalovirus titers (HR, 0.59; 95% CI, 0.38-0.93; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u2009.02) and high ultraviolet radiation exposure in the year before (HR, 0.52; 95% CI, 0.37-0.74; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and the year after (HR, 0.54, 95% CI, 0.38-0.75; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) diagnosis reduced the risk of MS symptoms. For all these prognostic factors, the multivariable analysis yielded similar results. The combination of high serum NfL <jats:italic toggle=\"yes\">z<\/jats:italic> scores and positive immunoglobulin G OBs conferred a 5-year risk of clinical symptoms of 58.3% (95% CI, 45.9-67.9). This risk increased to 81.6% (95% CI, 60.9-91.4) in pwRIS who were younger and positive for immunoglobulin M OBs.<\/jats:p><\/jats:sec><jats:sec id=\"ab-noi250029-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>The study elucidates the prognostic factors that significantly impact the risk of developing MS symptoms in pwRIS at diagnosis, thereby, enhancing the potential for tailored clinical interventions.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.1481","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T11:01:07Z","timestamp":1748862067000},"page":"722","source":"Crossref","is-referenced-by-count":26,"title":["Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome"],"prefix":"10.1001","volume":"82","author":[{"given":"Nicol\u00e1s","family":"Fissolo","sequence":"first","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) - ISCIII, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schaedelin","sequence":"additional","affiliation":[{"name":"Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland"},{"name":"Department of Neurology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland"},{"name":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa M.","family":"Villar","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Immunology, Hospital Universitario Ram\u00f3n y Cajal, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan D.","family":"L\u00fcnemann","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Translational Neurology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Correale","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fleni, Buenos Aires, Argentina; Institute of Biological Chemistry and Biophysics, CONICET\/University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Rejdak","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Lublin, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Schwab","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Translational Neurology, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Vilaseca","sequence":"additional","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Held","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine and Health, Technical University of Munich, Klinikum rechts der Isar, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Garc\u00eda-Merino","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Instituto de Investigaci\u00f3n Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bittner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (Rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Trojano","sequence":"additional","affiliation":[{"name":"Department of Translational Biomedicines and Neurosciences, University of Bari Aldo Moro, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Furlan","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[{"name":"Neuroinmunology Unit, University and Polytechnic La Fe Hospital, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igal","family":"Rosenstein","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda, Ospedale Maggiore Policlinico, Milan, Italy"},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"\u00c1lvarez-Bravo","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Dr. Josep Trueta University Hospital, Girona Biomedical Research Institute (IDIBGI), Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thouvenot","sequence":"additional","affiliation":[{"name":"Department of Neurology, N\u00eemes University Hospital, N\u00eemes, France"},{"name":"Institut de G\u00e9nomique Fonctionnelle, Univ Montpellier, CNRS, INSERM, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Llufriu","sequence":"additional","affiliation":[{"name":"Service of Neurology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Center of Neuroimmunology, Hospital Cl\u00ednic of Barcelona, Institut d\u2019Investigacions Biom\u00e8diques, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mart\u00ednez-Y\u00e9lamos","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Unit, Department of Neurology, Hospital Universitari de Bellvitge. Neurology and Neurogenetics Group, Neuroscience Program, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), Department of Clinical Sciences, School of Medicine, Universitat de Barcelona (UB), L\u2019Hospitalet de Llobregat, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hegen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[{"name":"Clinic of Neurology, University Clinical Center of Serbia, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"T\u00e9llez-Lara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Cl\u00ednico Universitario de Valladolid, Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Oechtering","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland"},{"name":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"P\u00e9rez-Sempere","sequence":"additional","affiliation":[{"name":"Hospital General Universitario de Alicante, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Rodr\u00edguez-Antig\u00fcedad","sequence":"additional","affiliation":[{"name":"Neurology Department, Cruces-BioCruces Bizkaia University Hospital, Barakaldo-Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Enrique-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Neurology Department, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Strijbis","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Killestein","sequence":"additional","affiliation":[{"name":"MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Location VU Medical Centre, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eichau","sequence":"additional","affiliation":[{"name":"Neurology Department, Virgen Macarena University Hospital, Sevilla, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Colombo","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Centre, IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Schaller-Nagengast","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Midaglia","sequence":"additional","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Neuroimmunology Unit, Instituto de Investigaci\u00f3n Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Monreal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Universitario Ram\u00f3n y Cajal, REEM, IRYCIS, Universidad de Alcal\u00e1, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charit\u00e9 Universitaetsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0lex","family":"Rovira","sequence":"additional","affiliation":[{"name":"Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d\u2019Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Tintor\u00e9","sequence":"additional","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Universitat de Vic-Universitat Central de Catalunya (Uvic-UCC), Vic, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lycke","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Zipp","sequence":"additional","affiliation":[{"name":"Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (Rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine and Health, Technical University of Munich, Klinikum rechts der Isar, M\u00fcnchen, Germany"},{"name":"Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland"},{"name":"Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Montalban","sequence":"additional","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) - ISCIII, Madrid, Spain"},{"name":"Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Comabella","sequence":"additional","affiliation":[{"name":"Servei de Neurologia and Centre d\u2019Esclerosi M\u00faltiple de Catalunya (Cemcat), Institut de Recerca Vall d\u2019Hebron (VHIR), Hospital Universitari Vall d\u2019Hebron. Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) - ISCIII, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"RIS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"noi250029r1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S1474-4422(23)00281-8","article-title":"Radiologically isolated syndrome.","volume":"22","author":"Lebrun-Frenay","year":"2023","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi250029r2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"noi250029r3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1352458517717808","article-title":"Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.","volume":"24","author":"De Stefano","year":"2018","journal-title":"Mult Scler"},{"issue":"8","key":"noi250029r4","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1093\/brain\/awad073","article-title":"The radiologically isolated syndrome: revised diagnostic criteria.","volume":"146","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"Brain"},{"issue":"2","key":"noi250029r5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.24564","article-title":"Primary progressive multiple sclerosis evolving from radiologically isolated syndrome.","volume":"79","author":"Kantarci","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"noi250029r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090509","article-title":"Radiologically isolated syndrome: 5-year risk for an initial clinical event.","volume":"9","author":"Okuda","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"noi250029r7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.25799","article-title":"Radiologically isolated syndrome: 10-year risk estimate of a clinical event.","volume":"88","author":"Lebrun-Frenay","year":"2020","journal-title":"Ann Neurol"},{"key":"noi250029r8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866092","article-title":"Biological markers in early multiple sclerosis: the paved way for radiologically isolated syndrome.","volume":"13","author":"Rival","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"noi250029r9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/jamaneurol.2023.2815","article-title":"Teriflunomide and time to clinical multiple sclerosis in patients with radiologically isolated syndrome: the TERIS randomized clinical trial.","volume":"80","author":"Lebrun-Fr\u00e9nay","year":"2023","journal-title":"JAMA Neurol"},{"issue":"3","key":"noi250029r10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ana.26555","article-title":"Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome.","volume":"93","author":"Okuda","year":"2023","journal-title":"Ann Neurol"},{"issue":"2","key":"noi250029r11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"2","key":"noi250029r12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.","volume":"122","author":"Reiber","year":"1994","journal-title":"J Neurol Sci"},{"issue":"2","key":"noi250029r13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis.","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"issue":"1-2","key":"noi250029r14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0022-1759(01)00492-6","article-title":"A sensitive and reproducible method for the detection of oligoclonal IgM bands.","volume":"258","author":"Villar","year":"2001","journal-title":"J Immunol Methods"},{"issue":"6","key":"noi250029r15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"issue":"5","key":"noi250029r16","first-page":"410","article-title":"Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.","volume":"95","author":"Fissolo","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"noi250029r17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"noi250029r18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2018457118","article-title":"Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.","volume":"118","author":"Ostkamp","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"noi250029r19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"issue":"3","key":"noi250029r20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","article-title":"Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis.","volume":"80","author":"Meier","year":"2023","journal-title":"JAMA Neurol"},{"issue":"10","key":"noi250029r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28271","article-title":"Risk factors and time to clinical symptoms of multiple sclerosis among patients with radiologically isolated syndrome.","volume":"4","author":"Lebrun-Fr\u00e9nay","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"noi250029r22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awy021","article-title":"Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.","volume":"141","author":"Matute-Blanch","year":"2018","journal-title":"Brain"},{"issue":"6","key":"noi250029r23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200156","article-title":"Kappa free light chain index predicts disease course in clinically and radiologically isolated syndromes.","volume":"10","author":"Levraut","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"noi250029r24","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200044","article-title":"Neurofilament light chain levels are predictive of clinical conversion in radiologically isolated syndrome.","volume":"10","author":"Rival","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"noi250029r25","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1111\/ene.14961","article-title":"Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study.","volume":"28","author":"Grut","year":"2021","journal-title":"Eur J Neurol"},{"issue":"9","key":"noi250029r26","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review.","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"23","key":"noi250029r27","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2217\/epi-2020-0172","article-title":"Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers.","volume":"12","author":"Mu\u00f1oz-San Mart\u00edn","year":"2020","journal-title":"Epigenomics"},{"key":"noi250029r28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1038393","article-title":"Multiple sclerosis and obesity: The role of adipokines.","volume":"13","author":"Correale","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"noi250029r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007638","article-title":"IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.","volume":"4","author":"Brettschneider","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"noi250029r30","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1007\/s00415-022-11519-8","article-title":"Adipokines in multiple sclerosis patients are related to clinical and radiological measures.","volume":"270","author":"Loonstra","year":"2023","journal-title":"J Neurol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2834601\/jamaneurology_fissolo_2025_oi_250029_1760122933.256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:03:25Z","timestamp":1760367805000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2834601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.1481","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}